Albert Wiegman, born in Amsterdam, the Netherlands, became a paediatrician and member of staff at the Amsterdam University Medical Centers in March 1991. In January 1993, he completed his sub-specialization in paediatric cardiology. In that same year, the Paediatric-Lipid Department came under his care and he started his research into the treatment of familial hypercholesterolaemia in children. He brought the research to completion in his thesis: ‘Paediatric Implications of Heterozygous Familial Hypercholesterolaemia’. In March 2020, he was appointed Associate Professor and Principal Investigator. Over the last 30 years, more than 4000 children with inherited dyslipidaemias have visited his ward, and he and his team have published over 100 articles in highly ranked international journals related to these disorders.